Resource July 2, 2024 JMCP Findings - Optimizing the Management of Inherited Blood Disorders Part 2 Health care leaders will need plans for handling new treatments for inherited blood disorders. This might mean changing benefits for treatments to make sure patients can get gene therapy. Market Insights, Inherited Blood Disorder
AMCP In The News July 2, 2024 Center for Biosimilars Managed Care and Specialty Pharmacy Stakeholders Weigh in on Strategies to Address Biosimilar Barriers Specialty Pharmacy
AMCP In The News July 2, 2024 Specialty Pharmacy Continuum Digital Therapeutics Ripe for a Surge During COVID-19 Prescription Digital Therapeutics
AMCP In The News July 2, 2024 MedCity News Digital Therapeutics Make Strides During Pandemic, but Still Face Adoption Hurdles
AMCP In The News July 2, 2024 American Journal of Managed Care PATHWAYS: Oncology Care Pathways Launched By Payers: What are the Trends?
AMCP In The News July 2, 2024 AiThority Sept. 9, 2021: AMCP Partnership Forum Develops Steps to Strengthen Evaluation of Digital Therapeutics AiThority Sept. 9, 2021: AMCP Partnership Forum Develops Steps to Strengthen Evaluation of Digital Therapeutics
AMCP In The News July 2, 2024 Pear Therapeutics Oct. 19, 2021: Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest, Provides Roadmap for Payer Coverage Considerations Pear Therapeutics Oct. 19, 2021: Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest, Provides Roadmap for Payer Coverage Considerations
AMCP In The News July 2, 2024 Managed Healthcare Executive AMCP 2022: Digital Therapeutics and the Medical, Pharmacy Benefit: Which Side Should They Go On?
